Call For Papers – 2012 Workshop on Pharmaco-Informatics for Drug Discovery Philadelphia, USA October 4-7, 2012 http://www.biocon.re.kr/BIBM2012PIDD in Conjunction with 2012 IEEE International Conference on Bioinformatics and Biomedicine (BIBM 2012) Background The advances of genomics, proteomics, chemoinformatics, and other systems-based scientific approaches have raised expectations on novel targets for drug discovery. Similarly, advances in protein engineering sciences and medicinal chemistries raised
Notice
4월 24일 연구단 논문이 Journal of Molecular Cell Biology에 게재되었습니다. 논문 제목은 “Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer”입니다. 자세한 내용은 http://www.biocon.re.kr/7670 를 참고 하시기 바랍니다.
The collaboration work with prof. Sung Ho Ryu regarding LRS was publisehd in Cell officially. Last month, the LRS article was published in early online publication and now it is officially published in Cell. it is also listed in Molecular Cell (Referred to Previews in Molecular Cell, 46, 4-6, 2012) The LRS article is the collaboration work with prof. Sungho
The article written by prof. Seung Bum Park (Bicon PI) was published in Angewnte Chemie International Edition, one of the top chemistry Journal. Especially, it was selected as the front cover. Its title is ““Discovery and Target Identification of an Antiproliferative Agent in Live Cells Using Fluorescence Difference in Two-Dimensional Gel Electrophoresis”
I. 연구사업 공모계획(안)교육과학기술부 글로벌프론티어사업을 수행하고 있는 (재)의약바이오컨버젼스연구단에서 2차년도 신규 연구과제를 공모합니다. □ 공모개요 ○ 지원대상: 국가 연구 과제 수행에 결격 사유가 없는 자 ○ 연구기간: 년 단위로 심사 후 업적 평가 및 지원여부 결정 ○ 공모기간: 2012년 4월 17일 (화)까지 ○ 연구사업의 지원분야는 RFP 참조 ○ 제출서류: 연구개발계획서 1부 (10 페이지 이내) ○ 선정 평가시 내/외부 관련
In 2012 KHUPO (held by SNU), Min Young Park (in the Ph.D. program) was awarded Young Scientist award. He presented a poster about “Quantitative proteome analysis of lung cancer EMT (epithelial cell to mesenchymal cell transition) process to investigate ARS’s novel roles in metastasis” and got the award for it.
This coming may 17th to 18th, a workshop with Japan physico-chemistry lab (RIKEN) will be held in Nami island. The workshop is about “Discovering new medicines and bio-convergence”. It is a good opportunity to observe how RIKEN is handling bio-convergence and what differences do they have compared to SNU. I aniticipate to see many PIs in the workshop. A
The article, which was published in cell recently, was nominated as ‘Faculty of 1000 Biology’. Faculty of 1000 Biology is the online database that searches for outstanding articles. The title of the article is “Human Leucyl-tRNA Synthetase Is an Intracellular Leucine Sensor for the mTORC1 Signaling Pathway.” Dr. Jung Min Han collaborated with Prof. Sung Ho Ryu (POSTEC) for the
The article by Dr. Min Chul Park regarding GRS antitumor cytokine was selected as Science Signlaing editor’s choice.
의약바이오컨버젼스연구단은 지난 3월 27일 일동제약 회의실에서 공동연구개발 협약식을 가졌습니다. 공동연구개발 내용은 “항암단백질 GRS단편을 이용한 신규 펩타이드 항암치료제”입니다. 이날 협약식에는 김성훈 단장님, 일동제약 이정치 회장님, 서울대 산단 이준식 단장님이 참석하셨습니다.